Shared on31 Jul 25
With Gentex’s future P/E and discount rate both essentially unchanged, analysts’ fair value assessment remains steady, keeping the consensus price target at $30.00. What's in the News Gentex completed the repurchase of 24,350,953 shares (10.58%) for $674.3 million under its 2021 buyback; a new buyback program authorizing up to 40,000,000 shares was approved by the Board.
Shared on30 Apr 25Fair value Decreased 3.92%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25Fair value Decreased 1.50%
AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.
Shared on17 Apr 25Fair value Decreased 5.45%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.56%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 0.47%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Decreased 2.60%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.